Literature DB >> 32297911

Positron Emission Tomography Imaging of Poly-(Adenosine Diphosphate-Ribose) Polymerase 1 Expression in Breast Cancer: A Nonrandomized Clinical Trial.

Elizabeth S McDonald1, Robert K Doot1, Austin R Pantel1, Michael D Farwell1, Robert H Mach1, Kara N Maxwell2, David A Mankoff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32297911      PMCID： PMC7163777          DOI： 10.1001/jamaoncol.2020.0334

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow.

Authors:  Todd A Hopkins; William B Ainsworth; Paul A Ellis; Cherrie K Donawho; Enrico L DiGiammarino; Sanjay C Panchal; Vivek C Abraham; Mikkel A Algire; Yan Shi; Amanda M Olson; Eric F Johnson; Julie L Wilsbacher; David Maag
Journal:  Mol Cancer Res       Date:  2018-11-14       Impact factor: 5.852

2.  A PET imaging agent for evaluating PARP-1 expression in ovarian cancer.

Authors:  Mehran Makvandi; Austin Pantel; Lauren Schwartz; Erin Schubert; Kuiying Xu; Chia-Ju Hsieh; Catherine Hou; Hyoung Kim; Chi-Chang Weng; Harrison Winters; Robert Doot; Michael D Farwell; Daniel A Pryma; Roger A Greenberg; David A Mankoff; Fiona Simpkins; Robert H Mach; Lilie L Lin
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

Review 3.  Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data.

Authors:  Elodie Chartron; Charles Theillet; Séverine Guiu; William Jacot
Journal:  Crit Rev Oncol Hematol       Date:  2018-11-05       Impact factor: 6.312

4.  BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.

Authors:  Kara N Maxwell; Bradley Wubbenhorst; Brandon M Wenz; Daniel De Sloover; John Pluta; Lyndsey Emery; Amanda Barrett; Adam A Kraya; Ioannis N Anastopoulos; Shun Yu; Yuchao Jiang; Hao Chen; Nancy R Zhang; Nicole Hackman; Kurt D'Andrea; Robert Daber; Jennifer J D Morrissette; Nandita Mitra; Michael Feldman; Susan M Domchek; Katherine L Nathanson
Journal:  Nat Commun       Date:  2017-08-22       Impact factor: 14.919

5.  A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity.

Authors:  Stephen J Pettitt; Farah L Rehman; Ilirjana Bajrami; Rachel Brough; Fredrik Wallberg; Iwanka Kozarewa; Kerry Fenwick; Ioannis Assiotis; Lina Chen; James Campbell; Christopher J Lord; Alan Ashworth
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

6.  A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy.

Authors:  Mehran Makvandi; Kuiying Xu; Brian P Lieberman; Redmond-Craig Anderson; Samuel Sander Effron; Harrison D Winters; Chenbo Zeng; Elizabeth S McDonald; Daniel A Pryma; Roger A Greenberg; Robert H Mach
Journal:  Cancer Res       Date:  2016-06-03       Impact factor: 13.312
  6 in total
  8 in total

Review 1.  The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1.

Authors:  Hsiaoju S Lee; Sally W Schwarz; Erin K Schubert; Delphine L Chen; Robert K Doot; Mehran Makvandi; Lilie L Lin; Elizabeth S McDonald; David A Mankoff; Robert H Mach
Journal:  Radiol Imaging Cancer       Date:  2022-01

2.  Building the Bridge: Molecular Imaging Biomarkers for 21st Century Cancer Therapies.

Authors:  Mark A Sellmyer; Iris K Lee; David A Mankoff
Journal:  J Nucl Med       Date:  2021-08-26       Impact factor: 11.082

Review 3.  Novel applications of molecular imaging to guide breast cancer therapy.

Authors:  Christine E Edmonds; Sophia R O'Brien; David A Mankoff; Austin R Pantel
Journal:  Cancer Imaging       Date:  2022-06-21       Impact factor: 5.605

4.  In vivo visualization of PARP inhibitor pharmacodynamics.

Authors:  Elizabeth S McDonald; Austin R Pantel; Payal D Shah; Michael D Farwell; Amy S Clark; Robert K Doot; Daniel A Pryma; Sean D Carlin
Journal:  JCI Insight       Date:  2021-04-22

5.  Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted 18F-Fluorthanatrace PET Images of Ovarian Cancer.

Authors:  Anthony J Young; Austin R Pantel; Varsha Viswanath; Tiffany L Dominguez; Mehran Makvandi; Hsiaoju Lee; Shihong Li; Erin K Schubert; Daniel A Pryma; Michael D Farwell; Robert H Mach; Fiona Simpkins; Lilie L Lin; David A Mankoff; Robert K Doot
Journal:  J Nucl Med       Date:  2021-04-16       Impact factor: 11.082

Review 6.  DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy.

Authors:  Nghia T Nguyen; Anna Pacelli; Michael Nader; Susanne Kossatz
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

7.  Imaging PARP with [18F]rucaparib in pancreatic cancer models.

Authors:  Chung Ying Chan; Zijun Chen; Gianluca Destro; Mathew Veal; Doreen Lau; Edward O'Neill; Gemma Dias; Michael Mosley; Veerle Kersemans; Florian Guibbal; Véronique Gouverneur; Bart Cornelissen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-26       Impact factor: 10.057

8.  Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma.

Authors:  Chung Ying Chan; Samantha L Hopkins; Florian Guibbal; Anna Pacelli; Julia Baguña Torres; Michael Mosley; Doreen Lau; Patrick Isenegger; Zijun Chen; Thomas C Wilson; Gemma Dias; Rebekka Hueting; Véronique Gouverneur; Bart Cornelissen
Journal:  EJNMMI Res       Date:  2022-10-09       Impact factor: 3.434
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.